Slate Business artwork

What Next TBD: The Summer Vaccine of the Future

Slate Business

English - September 04, 2022 07:00 - 20 minutes
Management Business News Business News Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed


LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.
Guest: Cassandra Willyard
Host: Lizzie O'Leary
Learn more about your ad choices. Visit megaphone.fm/adchoices

LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.

Guest: Cassandra Willyard

Host: Lizzie O'Leary

Learn more about your ad choices. Visit megaphone.fm/adchoices

Twitter Mentions